Latest Commercialization News

AdAlta Limited reported a $2.44 million loss for H1 FY26 while progressing a key CAR-T therapy collaboration and raising $2.8 million in capital. The company’s ‘East to West’ immunotherapy strategy gains momentum with regulatory tailwinds and cost efficiencies.

Newmont Corporation’s 2025 Annual Report reveals a robust financial performance driven by higher gold prices and portfolio optimisation, alongside significant progress in key development projects and sustainability initiatives.

BSP Financial Group has reported a robust 12.9% increase in net profit for 2025, underpinned by strong revenue growth and strategic restructuring, including converting its Fiji branch into a wholly owned subsidiary.

Temas Resources has launched a major re-assay initiative on historic drill core at its La Blache project, aiming to identify valuable metals like gallium, scandium, and chromium while saving millions in drilling costs.

Li-S Energy narrows its loss to $1.21 million in H1 2026, propelled by a $7.8 million ARENA grant and key manufacturing milestones including Australia’s first lithium metal foil production line. Strategic defence and aerospace partnerships bolster its commercialisation drive.

Winton Land Limited reports a sharp 60% revenue decline in its interim results for H1 FY26 but narrows its net loss and progresses key development projects amid a cautious economic backdrop.

Talga Group’s application for a major Swedish government grant was declined due to budget constraints, yet the company remains on track with alternative financing to scale its graphite anode production.

Terragen Holdings reports a 23% reduction in half-year net loss amid strategic shifts and completes a $7 million equity raise to accelerate global commercialisation of its biological agricultural products.

Ronin Resources has clarified the cause behind recent unusual trading activity, confirming no undisclosed information and announcing the end of negotiations on a potential copper-gold project in Argentina.

Cyclopharm Limited is rapidly scaling its US presence for Technegas®, securing new contracts across federal institutions and major health networks in four key regions. The company aims for up to 300 installations by late 2026, boosting recurring revenue streams.

Great Divide Mining and Dart Mining report record high-grade gold, silver, and antimony assays from ongoing drilling at the Banshee prospect, advancing the Coonambula project towards a maiden resource estimate.

Alcidion has secured regulatory approval for its AI-powered clinical tool in Australia and the UK, paving the way for commercial rollout in its largest markets. This milestone strengthens its position in healthcare technology and opens new sales avenues.